1887

Journal of Medical Microbiology logo

Volume 54, Issue 4

Serotype incidence and antibiotic susceptibility of causing invasive disease in Scotland, 1999–2002 Free

Abstract

Pneumococcal disease remains an important cause of invasive and non-invasive disease in Scotland and elsewhere. The Scottish Meningococcus and Pneumococcus Reference Laboratory receives isolates of from diagnostic laboratories around Scotland. Here, the serogroups/types and antibiotic-susceptibility patterns of invasive isolates received between 1999 and 2002 are described. There were a total of 1741 invasive isolates received, the most common serogroups/types being 14 (19.8 %), 9 (10.2 %), 6 (8.3 %), 19 (7.9 %), 23 (7.9 %), 4 (6.5 %), 8 (6.4 %), 3 (5.7 %), 1 (3.8 %), 7 (3.8 %) and 18 (3.4 %). Importantly, serotypes 7 and 8 are not represented in the 7-, 9- and 11-valent pneumococcal conjugate polysaccharide vaccines. There were 67 (3.8 %) isolates considered penicillin non-susceptible, although no penicillin resistance (MIC ⩾ 0.002 mg ml) was recorded. One hundred and ninety-four (11.1 %) isolates, predominantly of serotype 14, were resistant to erythromycin, and 12 (0.7 %) were resistant to ciprofloxacin. This information provides an important dataset that will prove essential prior to and during the implementation of pneumococcal conjugate vaccines in the UK.

  • Received:
  • Accepted:
  • Published Online:
© Microbiology Society
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45718-0
2005-04-01
2024-04-27
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/4/JM540403.html?itemId=/content/journal/jmm/10.1099/jmm.0.45718-0&mimeType=html&fmt=ahah

References

  1. Bos J. M., Rumke H., Welte R., Postma M. J. 2003; Epidemiologic impact and cost-effectiveness of universal infant vaccination with a 7-valent conjugated pneumococcal vaccine in the Netherlands. Clin Ther 25:2614–2630 [CrossRef]
     [Google Scholar]
  2. Clarke S. C., Diggle M. A., Edwards G. F. 2001; Surveillance of pneumococcal disease in Scotland. SCIEH Weekly Report 35:2– 2
     [Google Scholar]
  3. Gertz R. E. Jr, McEllistrem M. C., Boxrud D. J. & 8 other authors; 2003; Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 41:4194–4216 [CrossRef]
     [Google Scholar]
  4. Kyaw M. H., Clarke S., Edwards G. F., Jones I. G., Campbell H. 2000; Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies. Epidemiol Infect 125:561–572 [CrossRef]
     [Google Scholar]
  5. Kyaw M. H., Jones I. G., Campbell H. 2002a; Prevalence of penicillin non-susceptible invasive pneumococcal disease in the elderly in Scotland, 1992–99. Scand J Infect Dis 34:559–563 [CrossRef]
     [Google Scholar]
  6. Kyaw M. H., Clarke S., Jones I. G., Campbell H. 2002b; Incidence of invasive pneumococcal disease in Scotland, 1988–99. Epidemiol Infect 128:139–147
     [Google Scholar]
  7. Kyaw M. H., Christie P., Clarke S. C., Mooney J. D., Ahmed S., Jones I. G., Campbell H. 2003; Invasive pneumococcal disease in Scotland, 1999–2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 37:1283–1291 [CrossRef]
     [Google Scholar]
  8. Mohan P. V., Heath P. T. 2001; Pneumococcal disease in childhood. Hosp Med 62:406–409 [CrossRef]
     [Google Scholar]
  9. Muhlemann K., Matter H. C., Tauber M. G., Bodmer T. 2003; Nationwide surveillance of nasopharyngeal Streptococcus pneumoniae isolates from children with respiratory infection, Switzerland, 1998–1999. J Infect Dis 187:589–596 [CrossRef]
     [Google Scholar]
  10. Obaro S., Adegbola R. 2002; The pneumococcus: carriage, disease and conjugate vaccines. J Med Microbiol 51:98–104
     [Google Scholar]
  11. Skoczynska A., Hryniewicz W. 2003; Genetic relatedness, antibiotic susceptibility, and serotype distribution of Streptococcus pneumoniae responsible for meningitis in Poland, 1997–2001. Microb Drug Resist 9:175–182 [CrossRef]
     [Google Scholar]
  12. Smart L. E. 1986; Serotyping of Streptococcus pneumoniae strains by coagglutination. J Clin Pathol 39:328–331 [CrossRef]
     [Google Scholar]
  13. Whitney C. G., Farley M. M., Hadler J. & 10 other authors; 2003; Decline in invasive pneumococcal disease after the introduction of protein–polysaccharide conjugate vaccine. N Engl J Med 348:1737–1746 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45718-0
Loading
Serotype incidence and antibiotic susceptibility of Streptococcus pneumoniae causing invasive disease in Scotland, 1999–2002
J. Med. Microbiol. 54, 327 (2005); https://doi.org/10.1099/jmm.0.45718-0
/content/journal/jmm/10.1099/jmm.0.45718-0
/content/journal/jmm/10.1099/jmm.0.45718-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error